Our Story
As the first AI-native organization to address social determinants of health (SDoH) in clinical trials, we are revolutionizing the clinical research industry by providing tech-enabled, comprehensive support to Clinical Research Organizations (CROs), academic medical centers, and life science companies. Our mission is to ensure that everyone, including underrepresented groups and emerging healthcare markets, has access to breakthrough research and life-saving innovative medicines.
Our Team
Dedication. Expertise. Passion.
Meet the passionate team dedicated to transforming clinical research.With diverse backgrounds in medicine, data science, regulatory affairs, and clinical research we are united by a common mission: to make groundbreaking medications and innovative clinical trials accessible to everyone. Together, we leverage cutting-edge technology and a patient-centric approach to enhance trial efficiency, ensure regulatory compliance, and improve patient outcomes. Meet the people driving our vision forward.
Our Mission
At Neotypica, we are pioneering the use of artificial intelligence to address social determinants of health (SDoH) in clinical trials. Our mission is to ensure that everyone, including underrepresented groups and emerging healthcare markets, has access to breakthrough research and life-saving innovative medicines. We provide culturally sensitive and comprehensive support to universities, foundations, and life science companies using innovative tech-enabled solutions.
Why
NEOTYPICA?
Comprehensive Support:
Tailored services for CROs, pharmaceutical companies, and healthcare providers.
Advanced Technology:
AI-enabled solutions to enhance trial efficiency and patient outcomes.
Patient-Centric Approach:
Focus on inclusivity and improving access to breakthrough clinical research for underrepresented groups.
Proven Success:
Successful collaborations and case studies demonstrating measurable improvements in trial efficiency and outcomes.